Get started
Author

Kristine Paridaens

Observed names: K Paridaens, K. Paridaens, Paridaens K, Paridaens, Kristine
ORCID: 0000-0001-6865-5415
Observed ORCID: 0000-0001-6865-5415
OpenAlex ID: A5036656487
Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey
2012 · Stefan Schreiber, Julián Panés, et al. · BMC Gastroenterology · 110
PDF
Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial
2021 · Dorit Vedel Ankersen, Petra Weimers, et al. · Journal of Medical Internet Research · 46
PDF
Management and treatment optimization of patients with mild to moderate ulcerative colitis
2023 · Ferdinando D’Amico, Ernesto Fasulo, et al. · Expert Review of Clinical Immunology · 38
Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
2018 · Silvio Danese, Rupa Banerjee, et al. · Intestinal Research · 33
PDF
Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis
2021 · Kristine Paridaens, John R. Fullarton, et al. · Current Medical Research and Opinion · 30
National differences in ulcerative colitis experience and management among patients from five European countries and Canada: An online survey
2012 · Stefan Schreiber, Julián Panés, et al. · Journal of Crohn s and Colitis · 29
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
2022 · Edouard Louis, Kristine Paridaens, et al. · BMJ Open Gastroenterology · 28
PDF
Gamification Concepts to Promote and Maintain Therapy Adherence in Children with Growth Hormone Deficiency
2018 · Sally Radovick, Eli Hershkovitz, et al. · J — Multidisciplinary Scientific Journal · 27
PDF
Inflammatory bowel disease meets fertility: A physician and patient survey
2023 · Sophie Vieujean, Michel De Vos, et al. · Digestive and Liver Disease · 24
Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial
2019 · Dorit Vedel Ankersen, Petra Weimers, et al. · World Journal of Gastroenterology · 24
PDF
Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
2020 · Virginia Solitano, Ferdinando D’Amico, et al. · Journal of Clinical Medicine · 23
PDF
Fertility and Assisted Reproductive Technologies Outcomes of Women with Non-surgically Managed Inflammatory Bowel Diseases: A Systematic Review
2022 · Sophie Vieujean, Michel De Vos, et al. · Journal of Crohn s and Colitis · 18
PDF
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
2023 · Bénédicte Caron, Vipul Jairath, et al. · Medicina · 17
PDF
Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review
2022 · Bénédicte Caron, Vipul Jairath, et al. · United European Gastroenterology Journal · 17
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild‐to‐moderate ulcerative colitis
2019 · Silvio Danese, Ailsa Hart, et al. · United European Gastroenterology Journal · 17
PDF
Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis
2022 · Paolo Angelo Cortesi, Gionata Fiorino, et al. · Alimentary Pharmacology & Therapeutics · 16
eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis
2020 · Dorit Vedel Ankersen, Petra Weimers, et al. · Scandinavian Journal of Gastroenterology · 15
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey
2023 · Tommaso Lorenzo Parigi, Sophie Vieujean, et al. · Microorganisms · 13
PDF
The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis
2024 · Kristine Paridaens, Matthew J. Freddi, et al. · Frontiers in Gastroenterology · 9
PDF
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis—The OPTIMISE Study
2024 · Silvio Danese, Gionata Fiorino, et al. · Journal of Clinical Medicine · 8
PDF
Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis
2023 · Kristine Paridaens, John R Fullarton, et al. · JGH Open · 8
PDF
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
2021 · Axel U. Dignass, Kristine Paridaens, et al. · Scandinavian Journal of Gastroenterology · 7
iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis
2023 · Ferdinando D’Amico, Fernando Magro, et al. · Journal of Clinical Medicine · 5
PDF
‘Treat to Target’ in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
2020 · Arianna Dal Buono, Giulia Roda, et al. · Current Drug Targets · 4
Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey
2024 · Ferdinando D’Amico, Vipul Jairath, et al. · Journal of Clinical Medicine · 3
PDF
Works count: 47
Citation count: 584
H-index: 16
I10-index: 18
Year
Topic
Type